Methamphetamine Use by Incarcerated Women: Comorbid Mood and Anxiety Problems

Women's Health Issues

Volumn 17, Issue 4, 2007, Pages 256-263

  Vik, Peter W ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; PRISONER; PSYCHIATRIC DIAGNOSIS; SYMPTOM;

ADULT; ANALYSIS OF VARIANCE; ANXIETY DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; IDAHO; METHAMPHETAMINE; MIDDLE AGED; MOOD DISORDERS; PRISONERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 34250813086     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2006.12.004     Document Type: Article

References (34)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (4th ed.) (1994) Washington, DC: Author.
2. Anglin M.D., Burke C., Perrochet B., Stamper W., and Dawud-Noursi S. History of the methamphetamine problem. Journal of Psychoactive Drugs 32 (2000) 137-141
3. Babor T.F., and Del Boca F.K. Just the facts: Enhancing measurement of alcohol consumption using self-report methods. In: Litten R.Z., and Allen J.P. (Eds). Measuring alcohol consumption: Psychosocial and biochemical methods (1992), Humana Press, Totowa, NJ 3-19
4. Brady K.T., and Sonne S.C. The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Research & Health 23 4 (1999) 263-271
5. Brown S.A., Myers M.G., Lippke L., Tapert S.F., Stewart D.G., and Vik P.W. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): A measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol 59 (1998) 427-438
6. Connors G.J., Donovan D.M., and DiClemente C.C. Substance abuse treatment and the stages of change: Selecting and planning interventions (2002), The Guilford Press, New York
7. Daniel A.E., Robins A.J., and Wilfley D.E. Lifetime and six-month prevalence of psychiatric disorders among sentenced female offenders. Bulletin of the American Academy of Psychiatry and the Law 16 (1988) 333-342
8. Del Boca F.K., and Noll J.A. Truth or consequences: The validity of self-report data in health services research on addictions. Addiction 95 Suppl. 3 (2000) S347-S360
9. Derogatis L.R. Brief Symptom Inventory: Administration, scoring, and procedures manual. (3rd ed.) (1993), National Computer Systems, Inc, Minneapolis
10. Endicott J., and Spitzer R.L. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35 (1978) 837-844
11. Grice D.E., Brady K.T., Dustan L.R., Malcolm R., and Kilpatrick D.G. Sexual and physical assault history and posttraumatic stress disorder in substance-dependent individuals. The American Journal on Addictions 4 (1995) 297-305
12. Jordan B.K., Schlenger W.E., Fairbank J.A., and Caddell J.M. Prevalence of psychiatric disorders among incarcerated women: Convicted felons entering prison. Archives of General Psychiatry 53 (1996) 513-519
13. Kalechstein A.D., Newton T.F., Longshore D., Anglin M.D., van Gorp W.G., and Gawin F.H. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neuroscience 12 (2000) 480-484
14. Kessler R.C., Crum R.M., Warner L.A., and Nelson C.B. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54 (1997) 313-321
15. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry 51 (1994) 8-19
16. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry 61 (2004) 73-84
17. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Auilar-Gaziola S., et al. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors 23 (1998) 893-908
18. Murray J.B. Psychophysiological aspects of amphetamine-methamphetamine abuse. Journal of Psychology 132 (1998) 227-237
19. Myrick H., Cluver H., and Swavely S. Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Psychiatric Clinics of North America 27 (2004) 649-659
20. Nelson-Zlupko L., Kauffman E., and Dore M.M. Gender differences in drug addiction and treatment: Implications for social work intervention with substance-abusing women. Social Work 40 (1995) 45-53
21. Powis B., Griffiths P., Gossop M., and Strang J. The differences between male and female drug users: Community samples of heroin and cocaine users compared. Substance Use and Misuse 31 (1996) 529-543
22. Ramlow B.E., White A.L., Watson D.D., and Leukefeld C.G. The needs of women with substance use problems: An expanded vision for treatment. Substance Use and Misuse 32 (1997) 1395-1404
23. Reiger D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Co-morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 264 (1990) 2511-2518
24. Riehman K.S., Iguchi M.Y., and Anglin M.D. Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Psychology of Addictive Behaviors 16 (2002) 333-337
25. Robins L.N., Helzer J.E., Croughan J., and Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry 38 (1981) 381-389
26. Rosenthal R.N., and Westreich L. Treatment of persons with dual diagnoses of substance use disorders and other psychological problems. In: McCrady B.S., and Epstein E.E. (Eds). Addictions: A comprehensive guidebook (1999), Oxford University Press, New York 439-476
27. Schuckit M.A. Alcohol and depression: A clinical perspective. Acta Psychiatrica Scandinavica 89 Suppl. 377 (1994) 28-32
28. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry 158 (2001) 1206-1214
29. Teplin L.A., Abram K.M., and McClelland G.M. Prevalence of psychiatric disorders among incarcerated women: Pretrial jail detainees. Archives of General Psychiatry 53 (1996) 505-512
30. Vik P.W., and Ross T. Methamphetamine use among incarcerated women. Journal of Substance Use 8 (2003) 69-77
31. Wallen J. A comparison of male and female clients in substance abuse treatment. Journal of Substance Abuse Treatment 9 (1992) 243-248
32. Weiss R.D., Najavits L.M., and Mirin S.M. Substance abuse and psychiatric disorders. In: Frances R.J., and Miller S.I. (Eds). Clinical textbook of addictive disorders. 2nd ed. (1998), The Guilford Press, New York 291-318
33. Zweben J.E. Psychiatric problems among alcohol and other drug dependent women. Journal of Psychoactive Drugs 28 (1996) 345-366
34. Zweben J.E., Cohen J., Christian D., Galloway G.P., Salinardi M., Parent D., et al. Psychiatric symptoms in methamphetamine users. American Journal on Addictions 13 (2004) 181-190